![No image](https://static.cymitquimica.com/public/img/category-default-logo.png)
Ctx and Impurities
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | CTX1 REF: 4Z-C-353001CAS: 501935-96-2 | - - - | To inquire | Fri 16 Aug 24 |
![]() | CTX1-d6 REF: 4Z-C-353002CAS: 501935-96-2 | - - - | To inquire | Fri 16 Aug 24 |
![]() | BMS-813160 REF: TM-T4584CAS: 1286279-29-5 | 99.75% | 62.00 €~1,613.00 € | Fri 16 Aug 24 |
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Ref: 4Z-C-353001
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Friday 16 Aug 2024
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Ref: 4Z-C-353002
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Friday 16 Aug 2024
![discount label](https://static.cymitquimica.com/public/img/discount.png)
BMS-813160
CAS:1286279-29-5
BMS-813160 is the first dual CCR2/CCR5 antagonist to enter Clinical development for cardiovascular.
Formula:
C25H40N8O2
Purity:
99.75%
Color and Shape:
Solid
Molecular weight:
484.64
Ref: TM-T4584
1mg | 62.00 € | ||
1ml | 145.00 € | ||
5mg | 134.00 € | ||
10mg | 183.00 € | ||
25mg | 334.00 € | ||
50mg | 555.00 € | ||
100mg | 792.00 € | ||
500mg | 1,613.00 € |
Estimated delivery in United States, on Friday 16 Aug 2024